SHOX2 ccfDNAm and its association with survival in melanoma patients treated with palliative immunotherapy. Credit: Clinical Chemistry (2024). DOI: 10.1093/clinchem/hvad230 If melanoma spreads, there are various therapies that can be used. However, there is still insufficient research into who responds to which therapy and whether resistance may develop over time. In a new study, Dr. Simon Fietz, assistant physician at the Clinic for Dermato-oncology & Phlebology at the Center for Skin Diseases at the University Hospital Bonn (UKB) and PD Dr. Dimo Dietrich, scientist at the Clinic and Polyclinic for Read More
HEALTH DAILY NEWS
Health News, Medical News, Medical conditions, Medical Tests & Procedures, Symptoms, Medical Diagnosis , Health Information, FDA alerts, Drug Watch, Product Watch, Medicine Articles, Welfare, Living